Annual report pursuant to Section 13 and 15(d)

BUSINESS (Details Narrative)

v3.8.0.1
BUSINESS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2017
Jul. 28, 2016
State of Incorporation Nevada  
BioCorRx Pharmaceuticals, Inc [Member]    
Licensing rights, carrying value $ 250,000  
BioCorRx Pharmaceuticals, Inc [Member] | BioCorRx, Inc [Member]    
Equity issued ownership   78.10%
Officer [Member] | BioCorRx Pharmaceuticals, Inc [Member]    
Equity issued ownership   21.90%